Nasal polyps are soft, painless growths on the lining of your nasal passages or sinuses, often resulting from chronic inflammation. While these benign growths themselves are not harmful ...

Full results from the trial will be presented at an upcoming medical meeting. Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal ...

(Alliance News) - AstraZeneca PLC on Friday said it received positive results from a trial of Tezspire as a treatment for chronic rhinosinusitis with nasal polyps. Chronic rhinosinusitis is a ...

The trial involved symptomatic adults with severe chronic rhinosinusitis with nasal polyps (CRSwNP) who were treated with standard care but still experienced symptoms. TEZSPIRE was administered ...

Tonsil stones, also known as tonsilloliths, are calcium debris deposits that form on the tonsils. While tonsil stones are usually not a health concern, they are often an indication of poor oral ...

WILMINGTON, Del. - AstraZeneca (NASDAQ:AZN) and Amgen (NASDAQ:AMGN) have announced positive outcomes from the Phase III WAYPOINT trial of TEZSPIRE (tezepelumab) for patients with severe chronic ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

A new therapy may delay Alzheimer's disease progression by years, according to a study by researchers at Texas A&M University College of Medicine. Published in the Journal of Extracellular ...

Now, new research from Emory University is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized ...

Dr. Albritton is a resident physician and Dr. Kingdom is Assistant Professor in the Department of Otolaryngology at Emory University School of Medicine, Atlanta, Ga. Albritton FD, Kingdom TT.